Canwen Jiang

About Canwen Jiang

A physician scientist and passionate drug developer with 25+ years of biotech/pharma industrial experience in clinical development, translational medicine, regulatory affairs, medical affairs, business development, and strategic financing. Solid track record in building and leading world class research, development and medical organizations to advance pipelines in several therapeutic areas, including genetic/rare disorders, ophthalmology, CV/metabolism, CNS, oncology/hematology, infectious diseases, and GI. In-depth understanding of regulatory framework, ICH-GCP, and multiple technology platforms (recombinant proteins, antibodies, ADC, and gene and cell therapy, small molecules, and medical devices).

Experience

1. Chief Development Officer and Chief Medical Officer

   AskBio Inc.

   Aug 2020 — Present · NC, US

   At AskBio, we are making history with every clinical advancement and aspire to turn hope into cures by unraveling new possibilities for genetic medicine. Our scientific co-founder, Jude Samulski, PhD, was the first to demonstrate that adeno-associated virus (AAV) could be cloned for therapeutic purposes. His groundbreaking research inspires our world-leading gene therapy platform that is bringing new therapeutics to patients. Our preclinical and clinical pipeline covers a broad range of genetic and pathway diseases including CNS, neuromuscular, metabolic, and cardiac disorders. We are advancing our clinical stage products to regulatory approvals with innovation, quality, and speed.To advance our expansive investigational product portfolio and deliver transformative medicines to patients, we are further strengthening our world-class Therapeutics organization with passionate gene therapy developers - outstanding professionals and leaders in translational medicine, clinical immunology, clinical research, biostatistics, clinical operations, regulatory affairs, medical affairs, GLP/GCP, and project management. Our strategic partnership with Bayer provides robust global infrastructure, outstanding resources, and extensive expertise. Please visit our website for opportunities. As a wholly-owned and independently-operated Bayer company, we are determined to continue our journey of success and growth.

Education

• Imperial College London

  Doctor of Philosophy (Ph.D.), Cardiology

• Hunan College of Medicine and Hunan College of Chinese Medicine

  Doctor of Medicine (M.D.), Medicine

Skills

• Clinical Development
• Molecular Biology
• Biotechnology
• Research and Development (R&D)
• Drug Development
• Biopharmaceuticals
• U.s. Food and Drug Administration (Fda)
• Medicine
• Pharmaceutical Industry
• Fda
• Infectious Diseases
• Strategy
• Medical Devices
• Clinical Research
• R&D
• Glp
• Pharmaceutics
• Drug Discovery
• Immunology
• Oncology
• Cell
• Clinical Trials
• CRO
• Commercialization
• Life Sciences
• Regulatory Affairs
• Lifesciences
• Cell Culture
• Technology Transfer
• Vaccines